1McKeage K,Goa KL. Insulin glargine:a review of its therapeutic use as a long-acting agent for the management of type 1and 2 diabete Mellitus[J].Drugs,2001,(11):1599-1624.doi:10.2165/00003495-200161110-00007.
2Hamann A,Matthaei S,Rosak C. A randomized clinical trica comparing breakfast dinner or bedtime administration of insulin glargine in patents wite type 1[J].Diabetes Care,2003,(06):1738-1744.doi:10.2337/diacare.26.6.1738.
3Rosenstock J,Schwartz SL,Clark CM. Basal insulin therapy in type 2 diabetes,28-week comparison of insulin glargine(HPE901)and NPH insulin[J].Diabetes Care,2001,(04):631-636.doi:10.2337/diacare.24.4.631.
